Treatment with broad-spectrum antibiotics often leads to side effects, as it affects not only the pathogens but also the “good” bacteria in the gut. A research team from Hannover Medical School (MHH)
The French National Research Agency for HIV, Viral Hepatitis and Emerging Infectious Diseases (ANRS MIE) and the German Center for Infection Research (DZIF) are launching a joint call for
The ongoing Bundibugyo ebolavirus (BDBV) outbreak in the Democratic Republic of the Congo is the second-largest Ebolavirus outbreak globally, with more than 6,000 confirmed cases and a mortality rate
The latest working session of the Parliamentary Group against Antimicrobial Resistance took place on Sept. 24th and focused on the implementation of the new EU pharmaceutical legislation and the
The Incubator for Antimicrobial Therapies in Europe, INCATE, aims to support innovators in the early stages of developing therapies in the field of antimicrobial resistance. The German Center for
Why do the gut microbiomes of people from industrialized and non-industrialized regions differ? A study by the research team led by DZIF scientist Prof. Till Strowig of the Helmholtz Centre for
This year, for the first time, the German Center for Infection Research (DZIF) is presenting the DZIF Rising Star Award for outstanding early-career DZIF scientists. Researchers can apply to the DZIF
In acute, life-threatening infections, rapidly characterizing the microorganisms in a patient sample can help guide diagnosis and treatment. This is possible by using computational methods known as
According to the World Health Organization (WHO), tuberculosis (TB) affects more than 10 million people and causes over a million deaths each year, making it one of the world’s deadliest infectious
An international working group led by the German Society for Infectious Diseases (DGI) has developed a guideline for personalized phage therapy. Twenty professional organizations, 18 international
